4.7 Article

Synthesis and self-assembly of corona-functionalised polymeric arsenical nanoparticles

Journal

EUROPEAN POLYMER JOURNAL
Volume 144, Issue -, Pages -

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.eurpolymj.2020.110235

Keywords

Organoarsenic polymers; Polymeric arsenicals; Organic arsenicals; RAFT; Self; Assembly; Polymer nanoparticles

Funding

  1. Royal Society [URF \R1\180274]
  2. Tata companies [URF \R1\180274]
  3. EU Erasmus + programme

Ask authors/readers for more resources

Polymeric arsenicals are a promising platform for functional and active materials in polymer and (bio)materials science, with the ability to form nanoparticles of different morphologies and stabilities by adjusting the composition. The diverse reactivity of organic arsenicals can be exploited to develop functionalized nanoparticles with potential therapeutic applications.
Polymeric arsenicals are emerging as an interesting platform for functional and (re)active materials in the field of polymer and (bio)materials science. Through exploiting the diverse and distinct reactivity of organic arsenicals in As(V), As(III) and As(I) oxidation states efficient methods for bioconjugation as well as hydrogel and nanoparticles formation have been reported. Here we expand on this body of work by reporting the synthesis of new amphiphilic block copolymeric arsenicals with a target composition of P((DMAm100-x-co AsAmx)-b-DAAm(100)) (P1, X = 0; P2, X = 5; P3, X = 20) which form nanoparticles (NP1-NP3; D-h = 49-71 nm) upon self-assembly in water. The mole fraction of the AsAm monomer appears to have an effect on the particle morphology and stability, with stability decreasing as a function of the AsAm mole fraction in the corona. The reactivity of the AsAm (As(V)) group has been exploited to modify the corona functionality via direct reduction (NPRed) and sequential reduction and thiol substitution (NPGSH). The resulting As(III)-functionalised nanoparticles (NPRed) exhibited concentration-dependent toxicity against human prostate adenocarcinoma epithelia cell (PC-3) alluding to future development of these particles for mono- or combination therapy within appropriate nanoparticle formulations.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available